| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |